MLSS Milestone Scientific Forecast, Technical & Fundamental Analysis
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures... Show more
MLSS is expected to report earnings to 0 cents per share on August 18
Q2'26
Est.
$-0.01
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
The last earnings report on May 14 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 82.63K shares outstanding, the current market capitalization sits at 34.89M.
A.I. Advisor
published General Information
General Information
a provider of subcutaneous injection technology for dental and medical applications
A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.
The Moving Average Convergence Divergence (MACD) for MLSS turned positive on July 06, 2026. Looking at past instances where MLSS's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 07, 2026. You may want to consider a long position or call options on MLSS as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
MLSS moved above its 50-day moving average on July 10, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for MLSS moved above the 200-day moving average on June 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MLSS advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for MLSS crossed bearishly below the 50-day moving average on June 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MLSS broke above its upper Bollinger Band on July 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MLSS entered a downward trend on July 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MLSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MLSS's P/B Ratio (15.267) is slightly higher than the industry average of (4.675). P/E Ratio (0.000) is within average values for comparable stocks, (193.447). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.510). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (3.671) is also within normal values, averaging (83.877).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
